Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid for hip osteoarthritis pain
2019-000757-31Phase 3Active
- Sponsor
- Martina Hansens Hospital
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in hip osteoarthritis and bone marrow edema (BME) comparing Zoledronic acid with Placebo (2 arms). Started Feb 2019; status: active.
02
Drugs
zoledronic acid
03
Conditions
hip osteoarthritisbone marrow edema (BME)
Beyond the preview
Go deeper on 2019-000757-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000757-31.